Jupiter Life Line Hospitals Faces Technical Shift Amid Flat Financial Performance
Jupiter Life Line Hospitals has recently experienced an evaluation adjustment reflecting changes in its technical trends, shifting to a mildly bearish stance. The company reported a flat performance for Q4 FY24-25, with a profit after tax of Rs 44.86 crore, and maintains a favorable return on capital employed and low debt-to-equity ratio.
Jupiter Life Line Hospitals, a midcap player in the hospital and healthcare services industry, has recently undergone an evaluation adjustment that reflects changes in its underlying technical trends. The stock's technical indicators have shifted, with the trend moving from a sideways position to a mildly bearish stance. In terms of key financial metrics, the company reported a flat performance for the quarter ending Q4 FY24-25, with a profit after tax of Rs 44.86 crore, which represents a decline of 6.5% compared to the previous four-quarter average. The return on equity stands at 14.3%, and the stock is currently trading at a price-to-book value of 7.1, indicating a valuation that may be considered expensive relative to its historical averages.
Despite generating an 11.59% return over the past year, the company's profits have increased by 22%, resulting in a PEG ratio of 2.3. Additionally, Jupiter Life Line Hospitals boasts a high return on capital employed at 20.63% and maintains a low debt-to-equity ratio, which is favorable. The stock also has significant institutional holdings at 25.59%, suggesting a level of confidence from larger investors.
For more insights on Jupiter Life Line Hospitals and its financial trend performance, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
